repealing the prescription drug affordability board.

HB 570 would repeal the Prescription Drug Affordability Board, ending its authority to regulate and monitor prescription drug prices in the state. The bill removes the state's mechanism for setting drug cost limits and overseeing pharmaceutical affordability programs. This change would directly affect the state's regulatory framework for managing drug pricing and patient costs. The bill has been held in committee without further progress after a vote deemed it "inexpedient to legislate."